Phone:
+1 877 302 8632
Fax:
+1 888 205 9894 (Toll-free)
E-Mail:
orders@antibodies-online.com

FcRn antibody

FcRn Reactivity: Human ELISA, IF, FACS, cELISA Host: Mouse Monoclonal DVN24 unconjugated
Catalog No. ABIN7539618
  • Key Features
    • High-quality FcRn antibody (Clone DVN24) for the detection of FcRn.
    • Highly specific for human FcRn, blocks the binding of IgG.
    • Contains Glycerol for better storage.
    Target See all FcRn Antibodies
    FcRn (IgG receptor FcRn (FcRn))
    Reactivity
    • 42
    • 4
    • 4
    • 1
    • 1
    • 1
    • 1
    • 1
    Human
    Host
    • 39
    • 8
    • 1
    Mouse
    Clonality
    • 40
    • 8
    Monoclonal
    Conjugate
    • 23
    • 5
    • 5
    • 5
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    This FcRn antibody is un-conjugated
    Application
    • 28
    • 27
    • 6
    • 6
    • 5
    • 3
    • 2
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    ELISA, Immunofluorescence (IF), Flow Cytometry (FACS), Cell-ELISA (cELISA)
    Characteristics
    based on recognition of the complete native protein expressed on transfected mammalian cells
    Purification
    Purified, Protein G
    Immunogen
    hFcRn
    Clone
    DVN24
    Isotype
    IgG2a kappa
    Top Product
    Discover our top product FcRn Primary Antibody
    Product Specific Information

    Limited uses of our FcRn antibody ABIN7539618 / DVN24

  • Application Notes
    Flow cytometry: 1.2 μg/10^6 cells ELISA: 1:200 - 1:400CELISA: 1:200 - 1:400For each application a titration should be performed to determine the optimal concentration.
    Restrictions
    For Research Use only
  • Buffer
    PBS pH 7.2 with 50% glycerol
    Handling Advice
    avoid repeated freezing and thawing
    Storage
    4 °C
  • Hubbard, Pyzik, Rath, Kozicky, Sand, Gandhi, Grevys, Foss, Menzies, Glickman, Fiebiger, Roopenian, Sandlie, Andersen, Sly, Baker, Blumberg: "FcRn is a CD32a coreceptor that determines susceptibility to IgG immune complex-driven autoimmunity." in: The Journal of experimental medicine, Vol. 217, Issue 10, (2021) (PubMed).

    Cines, Zaitsev, Rauova, Rux, Stepanova, Krishnaswamy, Sarkar, Kowalska, Zhao, Mast, Blumberg, McCrae, Poncz, Hubbard, Pyzik, Blumberg: "FcRn augments induction of tissue factor activity by IgG-containing immune complexes." in: Blood, Vol. 135, Issue 23, pp. 2085-2093, (2021) (PubMed).

    Grevys, Nilsen, Sand, Daba, Øynebråten, Bern, McAdam, Foss, Schlothauer, Michaelsen, Christianson, Roopenian, Blumberg, Sandlie, Andersen: "A human endothelial cell-based recycling assay for screening of FcRn targeted molecules." in: Nature communications, Vol. 9, Issue 1, pp. 621, (2018) (PubMed).

    Sand, Dalhus, Christianson, Bern, Foss, Cameron, Sleep, Bjørås, Roopenian, Sandlie, Andersen: "Dissection of the neonatal Fc receptor (FcRn)-albumin interface using mutagenesis and anti-FcRn albumin-blocking antibodies." in: The Journal of biological chemistry, Vol. 289, Issue 24, pp. 17228-39, (2014) (PubMed).

  • Target
    FcRn (IgG receptor FcRn (FcRn))
    Alternative Name
    Fc Receptor (FcRn) FcRn (FcRn Products)
    Synonyms
    FCRN antibody, alpha-chain antibody, FcRn antibody, Fc fragment of IgG receptor and transporter antibody, Fc receptor, IgG, alpha chain transporter antibody, FCGRT antibody, Fcgrt antibody
    Background
    The MHC class I-like Fc receptor (FcRn) is an intracellular trafficking Fc receptor that is uniquely responsible for the extended serum half-life of antibodies of the IgG subclass and their ability to transport across cellular barriers. By performing these functions, FcRn affects numerous facets of antibody biology and pathobiology. Its critical role in controlling IgG pharmacokinetics has been leveraged for the design of therapeutic antibodies and related biologics. FcRn also traffics serum albumin and is responsible for the enhanced pharmacokinetic properties of albumin-conjugated therapeutics.
    Synonyms: IgG receptor FcRn large subunit p51, Neonatal Fc receptor, FCGRT
    UniProt
    P55899
    Pathways
    Regulation of Leukocyte Mediated Immunity, Positive Regulation of Immune Effector Process
You are here:
Support